SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-025721
Filing Date
2021-05-10
Accepted
2021-05-10 06:04:16
Documents
122
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tlry-10q_20210331.htm   iXBRL 10-Q 3846119
2 EX-31.1 tlry-ex311_7.htm EX-31.1 13665
3 EX-31.2 tlry-ex312_6.htm EX-31.2 13651
4 EX-32.1 tlry-ex321_8.htm EX-32.1 7601
  Complete submission text file 0001564590-21-025721.txt   15701884

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tlry-20210331.xsd EX-101.SCH 102332
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tlry-20210331_cal.xml EX-101.CAL 106194
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlry-20210331_def.xml EX-101.DEF 345964
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20210331_lab.xml EX-101.LAB 682836
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20210331_pre.xml EX-101.PRE 577943
10 EXTRACTED XBRL INSTANCE DOCUMENT tlry-10q_20210331_htm.xml XML 3623840
Mailing Address 745 FIFTH AVENUE SUITE 1602 NEW YORK NY 10151
Business Address 745 FIFTH AVENUE SUITE 1602 NEW YORK NY 10151 519.322.8800
Tilray, Inc. (Filer) CIK: 0001731348 (see all company filings)

IRS No.: 824310622 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38594 | Film No.: 21905084
SIC: 2833 Medicinal Chemicals & Botanical Products